Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More companies join race for noninvasive glucose testing

This article was originally published in Clinica

Executive Summary

The first minimally or noninvasive glucose monitors by Cygnus and MiniMed have failed to set the market on fire, writes Shara Rosen. Neither company's product has managed to gain widespread acceptance by either physicians or patients. This leaves the race to commercialise a more consumer-friendly device wide open. Given that the worldwide market for glucose monitoring systems is estimated to reach $8.5 billion by 2005, it is not surprising that the number of contenders is growing.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075376

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel